Bumpus wins Presidential Early Career Award
Namandje Bumpus, associate professor of pharmacology and molecular sciences at the Johns Hopkins University, has won a Presidential Early Career Award for Scientists and Engineers. Established in 1996 during the Clinton administration, the awards are conferred annually following recommendations from government agencies. The young scientists, who are honored for doing innovative, independent research and demonstrating commitment to community service through scientific leadership, public education or community outreach, receive their awards at a White House ceremony.
President Barack Obama praised Bumpus and the 104 other winners of the government’s highest honor for young scientists. “These early-careerscientists are leading the way in our efforts to confront and understand challenges from climate change to our health and wellness,” the presidentsaid. “We congratulate these accomplished individuals and encourage them to continue to serve as an example of their incredible promise and ingenuity of the American people.”
Bumpus researches the molecular mechanisms underlying idiosyncratic, adverse events associated with the use of non-nucleoside reverse transcriptase inhibitors to treat HIV-1. She runs a lab at Hopkins that examines how drugs used to prevent and treat HIV infection are metabolized and seeks to aid in the development of next-generation therapies. Mitchell
Mitchell named chair of Hemispherx
William M. Mitchell, professor of pathology, microbiology and immunology at the Vanderbilt University School of Medicine, is the new chairman of the board of Hemispherx Biopharma, a Philadelphia-based biopharmaceutical company that develops and manufactures new drugs for the treatment of viral and immune-based disorders. Hemispherx’s flagship products include Alferon N Injection, a highly purified and glycosylated multispecies alpha interferon product, and Ampligen, an experimental immunotherapeutic drug for chronic fatigue syndrome.
Hemispherx has undergone several recent organizational changes, most notably the promotion of Thomas Equels as the new CEO.
Mitchell remains an independent director at Hemispherx, a role he has held since 1998. Goc
Goc named professional woman of the year VIP
The National Association of Professional Women has inducted Anna Goc into its VIP Professional Woman of the Year Circle. The NAPW is a networking organization for professional women that boasts 850,000 members and is aimed at facilitating interaction and an exchange of ideas among female leaders in various fields.
“I’m pleased to welcome Anna to the exceptional group of professional women,” said NAPW President Star Jones. “Her knowledge and experience in her industry are valuable assets to her company and community.”
Goc, who studied at Jagiellonian Unversity in Cracow, Poland, is a senior researcher at the Dr. Rath Research Institute in Santa Clara, Calif., where she leads a microbiology lab that develops treatments for bacterial and fungal infections. She was recognized by NAPW for her leadership in research and development. Snyder
Snyder writes genomics book for lay readers
Michael Snyder, director of the Center for Genomics and Personalized Medicine at Stanford University, has penned a book for the general public. Published by Oxford University Press, “ Genomics and Personalized Medicine: What Everyone Needs to Know” is intended to be an accessible guide to genomics and personal health.
Since the mapping of the human genome in 2003, genomics have become increasingly relevant in health care. Snyder, who runs a lab at Stanford that analyzes genomes and regulatory networks, employs a question-and-answer format and concise prose in his book to help readers grasp relevant terminology and access consumer-oriented genomics technologies and resources.
Written by Erik Chaulk